|
|
Lilin Wang, Dan Smith, Simona Bot, Luis Dellamary, Amy Bloom, Adrian Bot
J Clin Invest. 2002;
110(8):1175
doi:10.1172/JCI15536
Abstract |
Full text
| PDF

T
he adaptive immune response is triggered by recognition of T and B cell epitopes and is influenced by “danger” motifs that act via innate immune receptors. This study shows that motifs associated with noncoding RNA are essential features in the immune response reminiscent of viral infection, mediating rapid induction of proinflammatory chemokine expression, recruitment and activation of antigen-presenting cells, modulation of regulatory cytokines, subsequent differentiation of Th1 cells, isotype switching, and stimulation of cross-priming. The heterogeneity of RNA-associated motifs results in differential binding to cellular receptors, and specifically impacts the immune profile. Naturally occurring double-stranded RNA (dsRNA) triggered activation of dendritic cells and enhancement of specific immunity, similar to selected synthetic dsRNA motifs. Based on the ability of specific RNA motifs to block tolerance induction and effectively organize the immune defense during viral infection, we conclude that such RNA species are potent danger motifs. We also demonstrate the feasibility of using selected RNA motifs as adjuvants in the context of novel aerosol carriers for optimizing the immune response to subunit vaccines. In conclusion, RNA-associated motifs produced during viral infection bridge the early response with the late adaptive phase, regulating the activation and differentiation of antigen-specific B and T cells, in addition to a short-term impact on innate immunity.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(14)
| Title and authors |
Publication |
Year |
Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.
Bo Jin, Tao Sun, Xiao-Hong Yu, Chao-Qun Liu, Ying-Xiang Yang, Ping Lu, Shan-Feng Fu, Hui-Bin Qiu, Anthony E T Yeo
|
J. Biomed. Biotechnol.
|
2010 |
Impact of Toll-like receptor 2 expression in renal allograft rejection
U. Hoffmann, T. Bergler, M. Rihm, C. Pace, B. Kruger, B. Jung, S. W. Reinhold, S. Farkas, P. Rummele, B. K. Kramer, B. Banas
|
Nephrology Dialysis Transplantation
|
2010 |
Tumor-targeted delivery of siRNA by self-assembled nanoparticles.
Shyh-Dar Li, Yun-Ching Chen, Michael J Hackett, Leaf Huang
|
Mol. Ther.
|
2008 |
Adjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapy.
Grégory Verdeil, Kristi Marquardt, Charles D Surh, Linda A Sherman
|
Proc. Natl. Acad. Sci. U.S.A.
|
2008 |
A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer
A Riezebos-Brilman, M Walczak, J Regts, M G Rots, G Kamps, B Dontje, H Y Haisma, J Wilschut, T Daemen
|
Gene Ther
|
2007 |
Stable expression of shRNAs in human CD34+ progenitor cells can avoid induction of interferon responses to siRNAs in vitro
Marjorie A Robbins, Mingjie Li, Irene Leung, Haitang Li, Doris V Boyer, Yong Song, Mark A Behlke, John J Rossi
|
Nat Biotechnol
|
2006 |
Update on toll-like receptor ligands and allergy: Implications for immunotherapy
Anthony A. Horner
|
Curr Allergy Asthma Rep
|
2006 |
Ischemia-Reperfusion Injury Activates Innate Immunity in Rat Kidneys
Byung Soo Kim, Sun Woo Lim, Can Li, Jung Shim Kim, Bo Kyung Sun, Kyung Ohk Ahn, Sang Woo Han, Jin Kim, Chul Woo Yang
|
Transplantation
|
2005 |
Induction of human papilloma virus E6/E7-specific cytotoxic T-lymphocyte activity in immune-tolerant, E6/E7-transgenic mice
A Riezebos-Brilman, J Regts, E-J Freyschmidt, B Dontje, J Wilschut, T Daemen
|
Gene Ther
|
2005 |
Defining the Antigen-Specific T-Cell Response to Vaccination and Poly(I:C)/TLR3 Signaling
Mohamed L Salem, Andre N Kadima, David J Cole, William E Gillanders
|
Journal of Immunotherapy
|
2005 |
|